Showing results (791-800 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation StrategyJenny Viklund, Karin Kolmodin, Gunnar Nordvall, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical CandidateSamit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma bruceiAdel A Rashad, Amy J Jones, Vicky M Avery, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
New Hits as Antagonists of GPR103 Identified by HTSAnneli Nordqvist, Lisbeth Kristensson, Kjell E Johansson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Expansion of Antibacterial Spectrum of Muraymycins toward Pseudomonas aeruginosaYusuke Takeoka, Tetsuya Tanino, Mitsuaki Sekiguchi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase InhibitorsYongcong Lv, Mengyuan Li, Ting Liu, et al.
ACS Medicinal Chemistry Letters|January 21, 2014
Discovery of Novel Putative Inhibitors of UDP-GlcNAc 2-Epimerase as Potent Antibacterial AgentsYong Xu, Benjamin Brenning, Adrianne Clifford, et al.
ACS Medicinal Chemistry Letters|June 18, 2014
Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription CofactorQi Shi, Shaoman Yin, Stefan Kaluz, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Pageof 438